These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 991147)

  • 1. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
    Armitage JO; Burns CP
    Cancer Treat Rep; 1976 May; 60(5):585-9. PubMed ID: 991147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
    Cassileth PA; Kahn SB; Silber R; Weiler C
    Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute leukemia in adults with cytosine arabinoside and thioguanine].
    Kotlarek-Haus S; Lawińska B; Kuliszkiewicz-Janus M
    Acta Haematol Pol; 1978; 9(4):237-42. PubMed ID: 735711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
    Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
    Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance management of acute nonlymphocytic leukemia.
    Lewis JP; Pajak TF; Linman JW; Bateman JR
    Cancer Clin Trials; 1981; 4(2):115-24. PubMed ID: 7249249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
    Poth JL; Johnson PK; George RP; Schrier SL
    Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
    Lönnqvist B; Andersson B; Björkholm M; Engstedt L; Gahrton G; Hast R; Holm G; Killander A; Lantz B; Lockner D; Mellstedt H; Palmblad J; Paul C; Peterson C; Simonsson B; Stalfelt AM; Udén AM; Wadman B; Oberg G
    Cancer Chemother Pharmacol; 1982; 9(2):89-92. PubMed ID: 7172410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for acute nonlymphoblastic leukemia in adults.
    Glucksberg H; Buckner CD; Fefer A; DeMarsh Q; Coleman D; Dobrow RB; Huff J; Kjobech C; Hill AS; Dittman W; Neiman PE; Cheever MA; Einstein AB; Thomas ED
    Cancer Chemother Rep; 1975; 59(6):1131-7. PubMed ID: 769952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy of adult acute nonlymphoblastic leukemia: an argument against the need for central nervous system prophlyaxis.
    Armitage JO; Burns CP
    Cancer; 1978 Feb; 41(2):697-700. PubMed ID: 272947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acridinyl anisidide (m-AMSA) therapy in 11 patients with refractory acute leukemia.
    Naparstek E; Shinar E; Polliack A
    Isr J Med Sci; 1984 Feb; 20(2):118-22. PubMed ID: 6546740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia.
    Lewis JP; Linman JW; Marshall GJ; Pajak TF; Bateman JR
    Cancer; 1977 Apr; 39(4):1387-96. PubMed ID: 322835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission maintenance therapy in acute myelogenous leukemia.
    Embury SH; Elias L; Heller PH; Hood CE; Greenberg PL; Schrier SL
    West J Med; 1977 Apr; 126(4):267-72. PubMed ID: 266313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.
    Arlin ZA; Flomenberg N; Gee TS; Kempin SJ; Dellaquila C; Mertelsmann R; Straus DJ; Young CW; Clarkson BD
    Cancer Clin Trials; 1981; 4(3):317-21. PubMed ID: 6895190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanine.
    Mandelli F; Amadori S; De Luca AM; Deriu L; De Rossi G; Isacchi G; Mariani G; Monarca B; Papa G; Di Giovanni F
    Haematologica; 1977 Apr; 62(2):167-84. PubMed ID: 406174
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.